Dynavax Announces Second Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
Dynavax (DVAX) Tops Q2 EPS by 6c
August 4, 2021 5:18 PM EDTDynavax (NASDAQ: DVAX) reported Q2 EPS of $0.02, $0.06 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $52.77 million versus the consensus estimate of $41.59 million.
"Our successful execution in the second quarter of 2021 continued to build on the progress made in 2020. With the combined strength of opportunities from HEPLISAV-B and CpG 1018, we believe 2021 will be... More
